United States · FDA National Drug Code directory
PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-531_176f3856-e33d-4fb2-9fe9-72d96c5eabe8
- Product NDC
- 69097-531
- Form
- SUSPENSION
- Composition / generic term
- pantoprazole sodium granules
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250403
- Source listing expiry
- 20261231
Source-listed ingredients
- PANTOPRAZOLE SODIUM — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 PACKET in 1 CARTON (69097-531-53) / 1 SUSPENSION in 1 PACKET (69097-531-31) · 69097-531-53
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →